ZN148_HUMAN - dbPTM
ZN148_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID ZN148_HUMAN
UniProt AC Q9UQR1
Protein Name Zinc finger protein 148
Gene Name ZNF148
Organism Homo sapiens (Human).
Sequence Length 794
Subcellular Localization Nucleus.
Protein Description Involved in transcriptional regulation. Represses the transcription of a number of genes including gastrin, stromelysin and enolase. Binds to the G-rich box in the enhancer region of these genes..
Protein Sequence MNIDDKLEGLFLKCGGIDEMQSSRTMVVMGGVSGQSTVSGELQDSVLQDRSMPHQEILAADEVLQESEMRQQDMISHDELMVHEETVKNDEEQMETHERLPQGLQYALNVPISVKQEITFTDVSEQLMRDKKQIREPVDLQKKKKRKQRSPAKILTINEDGSLGLKTPKSHVCEHCNAAFRTNYHLQRHVFIHTGEKPFQCSQCDMRFIQKYLLQRHEKIHTGEKPFRCDECGMRFIQKYHMERHKRTHSGEKPYQCEYCLQYFSRTDRVLKHKRMCHENHDKKLNRCAIKGGLLTSEEDSGFSTSPKDNSLPKKKRQKTEKKSSGMDKESALDKSDLKKDKNDYLPLYSSSTKVKDEYMVAEYAVEMPHSSVGGSHLEDASGEIHPPKLVLKKINSKRSLKQPLEQNQTISPLSTYEESKVSKYAFELVDKQALLDSEGNADIDQVDNLQEGPSKPVHSSTNYDDAMQFLKKKRYLQAASNNSREYALNVGTIASQPSVTQAAVASVIDESTTASILESQALNVEIKSNHDKNVIPDEVLQTLLDHYSHKANGQHEISFSVADTEVTSSISINSSEVPEVTPSENVGSSSQASSSDKANMLQEYSKFLQQALDRTSQNDAYLNSPSLNFVTDNQTLPNQPAFSSIDKQVYATMPINSFRSGMNSPLRTTPDKSHFGLIVGDSQHSFPFSGDETNHASATSTQDFLDQVTSQKKAEAQPVHQAYQMSSFEQPFRAPYHGSRAGIATQFSTANGQVNLRGPGTSAEFSEFPLVNVNDNRAGMTSSPDATTGQTFG
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
6Sumoylation--MNIDDKLEGLFLK
--CCHHHHHHHHHHH
44.6928112733
22PhosphorylationGGIDEMQSSRTMVVM
CCCCHHHCCCEEEEE
22.0721955146
23PhosphorylationGIDEMQSSRTMVVMG
CCCHHHCCCEEEEEC
18.1921955146
25PhosphorylationDEMQSSRTMVVMGGV
CHHHCCCEEEEECCC
19.1018669648
33PhosphorylationMVVMGGVSGQSTVSG
EEEECCCCCCCCCCH
34.1021955146
36PhosphorylationMGGVSGQSTVSGELQ
ECCCCCCCCCCHHHC
34.0121955146
37PhosphorylationGGVSGQSTVSGELQD
CCCCCCCCCCHHHCC
15.7118669648
39PhosphorylationVSGQSTVSGELQDSV
CCCCCCCCHHHCCHH
27.0021955146
45PhosphorylationVSGELQDSVLQDRSM
CCHHHCCHHHCCCCC
16.2721955146
51PhosphorylationDSVLQDRSMPHQEIL
CHHHCCCCCCHHHHH
44.9830108239
88SumoylationMVHEETVKNDEEQME
HCCHHHCCCHHHHHH
67.1328112733
106PhosphorylationRLPQGLQYALNVPIS
HCCCHHHHHHCCCEE
20.3527642862
115SumoylationLNVPISVKQEITFTD
HCCCEEECEEEEECC
35.11-
115SumoylationLNVPISVKQEITFTD
HCCCEEECEEEEECC
35.1128112733
119PhosphorylationISVKQEITFTDVSEQ
EEECEEEEECCHHHH
21.5220860994
121PhosphorylationVKQEITFTDVSEQLM
ECEEEEECCHHHHHH
27.1720860994
132SumoylationEQLMRDKKQIREPVD
HHHHCCHHHHCCCCC
56.07-
132SumoylationEQLMRDKKQIREPVD
HHHHCCHHHHCCCCC
56.0728112733
147UbiquitinationLQKKKKRKQRSPAKI
HHHHHHHCCCCCCCE
59.9723000965
150PhosphorylationKKKRKQRSPAKILTI
HHHHCCCCCCCEEEE
27.0725849741
153UbiquitinationRKQRSPAKILTINED
HCCCCCCCEEEECCC
41.4523000965
156PhosphorylationRSPAKILTINEDGSL
CCCCCEEEECCCCCC
25.8121949786
162PhosphorylationLTINEDGSLGLKTPK
EEECCCCCCCCCCCC
31.4227251275
166UbiquitinationEDGSLGLKTPKSHVC
CCCCCCCCCCCCHHH
62.0729967540
167PhosphorylationDGSLGLKTPKSHVCE
CCCCCCCCCCCHHHH
40.7822199227
194PhosphorylationQRHVFIHTGEKPFQC
CCCEEEECCCCCCCC
42.0730576142
197UbiquitinationVFIHTGEKPFQCSQC
EEEECCCCCCCCCHH
53.10-
202PhosphorylationGEKPFQCSQCDMRFI
CCCCCCCCHHCHHHH
24.0630576142
222PhosphorylationQRHEKIHTGEKPFRC
HHHHCCCCCCCCCCC
50.9729496963
239SumoylationCGMRFIQKYHMERHK
HHHHHHHHHHHHHHC
32.10-
239UbiquitinationCGMRFIQKYHMERHK
HHHHHHHHHHHHHHC
32.1029967540
239SumoylationCGMRFIQKYHMERHK
HHHHHHHHHHHHHHC
32.10-
248PhosphorylationHMERHKRTHSGEKPY
HHHHHCCCCCCCCCC
25.7928152594
250PhosphorylationERHKRTHSGEKPYQC
HHHCCCCCCCCCCCC
48.2926055452
255PhosphorylationTHSGEKPYQCEYCLQ
CCCCCCCCCCHHHHH
36.5429214152
259PhosphorylationEKPYQCEYCLQYFSR
CCCCCCHHHHHHHHH
13.19-
291MethylationKLNRCAIKGGLLTSE
HHHHHHEECCCCCCC
28.53115978281
291UbiquitinationKLNRCAIKGGLLTSE
HHHHHHEECCCCCCC
28.5323000965
291AcetylationKLNRCAIKGGLLTSE
HHHHHHEECCCCCCC
28.5326051181
291SumoylationKLNRCAIKGGLLTSE
HHHHHHEECCCCCCC
28.5328112733
296PhosphorylationAIKGGLLTSEEDSGF
HEECCCCCCCCCCCC
38.8523927012
297PhosphorylationIKGGLLTSEEDSGFS
EECCCCCCCCCCCCC
38.6725159151
301PhosphorylationLLTSEEDSGFSTSPK
CCCCCCCCCCCCCCC
45.0422167270
304PhosphorylationSEEDSGFSTSPKDNS
CCCCCCCCCCCCCCC
31.3429255136
305PhosphorylationEEDSGFSTSPKDNSL
CCCCCCCCCCCCCCC
46.9529255136
306PhosphorylationEDSGFSTSPKDNSLP
CCCCCCCCCCCCCCC
28.8429255136
308SumoylationSGFSTSPKDNSLPKK
CCCCCCCCCCCCCHH
70.1228112733
311PhosphorylationSTSPKDNSLPKKKRQ
CCCCCCCCCCHHHHH
57.0722167270
324PhosphorylationRQKTEKKSSGMDKES
HHHHCHHCCCCCHHH
43.1029214152
325PhosphorylationQKTEKKSSGMDKESA
HHHCHHCCCCCHHHH
47.20-
329AcetylationKKSSGMDKESALDKS
HHCCCCCHHHHCCHH
44.6825953088
331PhosphorylationSSGMDKESALDKSDL
CCCCCHHHHCCHHHH
39.61-
335AcetylationDKESALDKSDLKKDK
CHHHHCCHHHHHCCC
46.8725953088
336PhosphorylationKESALDKSDLKKDKN
HHHHCCHHHHHCCCC
48.0925159151
342UbiquitinationKSDLKKDKNDYLPLY
HHHHHCCCCCCCCCC
61.6729967540
342AcetylationKSDLKKDKNDYLPLY
HHHHHCCCCCCCCCC
61.6725953088
345PhosphorylationLKKDKNDYLPLYSSS
HHCCCCCCCCCCCCC
21.4427642862
349PhosphorylationKNDYLPLYSSSTKVK
CCCCCCCCCCCCCCC
12.4527642862
350PhosphorylationNDYLPLYSSSTKVKD
CCCCCCCCCCCCCCC
26.0425159151
351PhosphorylationDYLPLYSSSTKVKDE
CCCCCCCCCCCCCCE
28.5925159151
352PhosphorylationYLPLYSSSTKVKDEY
CCCCCCCCCCCCCEE
26.7225159151
353PhosphorylationLPLYSSSTKVKDEYM
CCCCCCCCCCCCEEE
41.6325627689
356SumoylationYSSSTKVKDEYMVAE
CCCCCCCCCEEEEEE
46.53-
356SumoylationYSSSTKVKDEYMVAE
CCCCCCCCCEEEEEE
46.5325114211
400PhosphorylationKKINSKRSLKQPLEQ
HHCCCCCCCCCCHHC
43.5923403867
402UbiquitinationINSKRSLKQPLEQNQ
CCCCCCCCCCHHCCC
51.6329967540
402SumoylationINSKRSLKQPLEQNQ
CCCCCCCCCCHHCCC
51.6328112733
410PhosphorylationQPLEQNQTISPLSTY
CCHHCCCCCCCCHHH
30.8530266825
412PhosphorylationLEQNQTISPLSTYEE
HHCCCCCCCCHHHCH
24.1523927012
415PhosphorylationNQTISPLSTYEESKV
CCCCCCCHHHCHHHH
32.1230266825
416PhosphorylationQTISPLSTYEESKVS
CCCCCCHHHCHHHHH
42.5130266825
417PhosphorylationTISPLSTYEESKVSK
CCCCCHHHCHHHHHH
17.8330266825
420PhosphorylationPLSTYEESKVSKYAF
CCHHHCHHHHHHHHH
26.8123927012
421UbiquitinationLSTYEESKVSKYAFE
CHHHCHHHHHHHHHH
54.5329967540
421AcetylationLSTYEESKVSKYAFE
CHHHCHHHHHHHHHH
54.5326051181
421SumoylationLSTYEESKVSKYAFE
CHHHCHHHHHHHHHH
54.5328112733
423PhosphorylationTYEESKVSKYAFELV
HHCHHHHHHHHHHHH
24.5623312004
424SumoylationYEESKVSKYAFELVD
HCHHHHHHHHHHHHH
43.52-
424UbiquitinationYEESKVSKYAFELVD
HCHHHHHHHHHHHHH
43.5229967540
424SumoylationYEESKVSKYAFELVD
HCHHHHHHHHHHHHH
43.5228112733
424AcetylationYEESKVSKYAFELVD
HCHHHHHHHHHHHHH
43.5225953088
425PhosphorylationEESKVSKYAFELVDK
CHHHHHHHHHHHHHH
14.71-
432UbiquitinationYAFELVDKQALLDSE
HHHHHHHHHHHHCCC
29.9529967540
438PhosphorylationDKQALLDSEGNADID
HHHHHHCCCCCCCHH
47.5825159151
456AcetylationNLQEGPSKPVHSSTN
CCCCCCCCCCCCCCC
54.9425953088
456UbiquitinationNLQEGPSKPVHSSTN
CCCCCCCCCCCCCCC
54.9429967540
472UbiquitinationDDAMQFLKKKRYLQA
HHHHHHHHHHHHHHH
58.5029967540
496O-linked_GlycosylationLNVGTIASQPSVTQA
ECHHHCCCCCCHHHH
38.4831492838
501O-linked_GlycosylationIASQPSVTQAAVASV
CCCCCCHHHHHHHHH
19.4831492838
533UbiquitinationEIKSNHDKNVIPDEV
EECCCCCCCCCCHHH
45.6329967540
533AcetylationEIKSNHDKNVIPDEV
EECCCCCCCCCCHHH
45.6326051181
543PhosphorylationIPDEVLQTLLDHYSH
CCHHHHHHHHHHHCH
25.7327251275
549PhosphorylationQTLLDHYSHKANGQH
HHHHHHHCHHHCCCE
18.3227251275
559O-linked_GlycosylationANGQHEISFSVADTE
HCCCEEEEEEECCCE
14.4231492838
572O-linked_GlycosylationTEVTSSISINSSEVP
CEEEEEEEECCCCCC
20.0531492838
607AcetylationNMLQEYSKFLQQALD
HHHHHHHHHHHHHHH
49.5519608861
607UbiquitinationNMLQEYSKFLQQALD
HHHHHHHHHHHHHHH
49.5519608861
625PhosphorylationQNDAYLNSPSLNFVT
CCCCCCCCCCCCCCC
17.1722210691
627PhosphorylationDAYLNSPSLNFVTDN
CCCCCCCCCCCCCCC
35.4522210691
632PhosphorylationSPSLNFVTDNQTLPN
CCCCCCCCCCCCCCC
25.7028348404
636PhosphorylationNFVTDNQTLPNQPAF
CCCCCCCCCCCCCCC
50.8928348404
636O-linked_GlycosylationNFVTDNQTLPNQPAF
CCCCCCCCCCCCCCC
50.8931492838
644O-linked_GlycosylationLPNQPAFSSIDKQVY
CCCCCCCCCCCCCCE
28.6131492838
651PhosphorylationSSIDKQVYATMPINS
CCCCCCCEEECCCCH
8.2128796482
653PhosphorylationIDKQVYATMPINSFR
CCCCCEEECCCCHHC
13.0426074081
658PhosphorylationYATMPINSFRSGMNS
EEECCCCHHCCCCCC
23.8226074081
661PhosphorylationMPINSFRSGMNSPLR
CCCCHHCCCCCCCCC
40.1425159151
665PhosphorylationSFRSGMNSPLRTTPD
HHCCCCCCCCCCCCC
19.2029255136
669PhosphorylationGMNSPLRTTPDKSHF
CCCCCCCCCCCCCCC
50.8125159151
670PhosphorylationMNSPLRTTPDKSHFG
CCCCCCCCCCCCCCE
24.0523401153
683PhosphorylationFGLIVGDSQHSFPFS
CEEEECCCCCCCCCC
24.7026074081
686PhosphorylationIVGDSQHSFPFSGDE
EECCCCCCCCCCCCC
27.2926074081
702PhosphorylationNHASATSTQDFLDQV
CCCCCCCHHHHHHHH
28.0130576142
724PhosphorylationAQPVHQAYQMSSFEQ
CCCHHHHHHCCCCCC
9.7427642862
727PhosphorylationVHQAYQMSSFEQPFR
HHHHHHCCCCCCCCC
19.1528348404
728PhosphorylationHQAYQMSSFEQPFRA
HHHHHCCCCCCCCCC
27.7128348404
734MethylationSSFEQPFRAPYHGSR
CCCCCCCCCCCCCCC
41.14115920397
740PhosphorylationFRAPYHGSRAGIATQ
CCCCCCCCCCEEEEE
12.97-
749PhosphorylationAGIATQFSTANGQVN
CEEEEEEECCCCEEE
19.4528857561
749O-linked_GlycosylationAGIATQFSTANGQVN
CEEEEEEECCCCEEE
19.4531492838
750PhosphorylationGIATQFSTANGQVNL
EEEEEEECCCCEEEE
25.9828857561
762PhosphorylationVNLRGPGTSAEFSEF
EEECCCCCCCCCCCC
28.0924719451
763PhosphorylationNLRGPGTSAEFSEFP
EECCCCCCCCCCCCC
31.5426714015
767PhosphorylationPGTSAEFSEFPLVNV
CCCCCCCCCCCEEEC
29.8126074081
782PhosphorylationNDNRAGMTSSPDATT
CCCCCCCCCCCCCCC
25.7430266825
783PhosphorylationDNRAGMTSSPDATTG
CCCCCCCCCCCCCCC
30.8630266825
784PhosphorylationNRAGMTSSPDATTGQ
CCCCCCCCCCCCCCC
20.0326846344
788PhosphorylationMTSSPDATTGQTFG-
CCCCCCCCCCCCCC-
38.5530266825
789PhosphorylationTSSPDATTGQTFG--
CCCCCCCCCCCCC--
29.0723663014
792PhosphorylationPDATTGQTFG-----
CCCCCCCCCC-----
31.5023403867

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
202SPhosphorylationKinaseATMQ13315
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of ZN148_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of ZN148_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
CAVN1_HUMANPTRFphysical
10727401
P53_HUMANTP53physical
11416144
HDAC3_HUMANHDAC3physical
19583777
EP300_HUMANEP300physical
21828133
TRRAP_HUMANTRRAPphysical
21828133
KAT2A_HUMANKAT2Aphysical
21828133
ZN316_HUMANZNF316physical
22939629
TRI10_HUMANTRIM10physical
25416956
GLRX3_HUMANGLRX3physical
25416956
GORS2_HUMANGORASP2physical
25416956
NTM2F_HUMANNUTM2Fphysical
25416956
CEP70_HUMANCEP70physical
25416956
DEUP1_HUMANCCDC67physical
25416956

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of ZN148_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-607, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-306; SER-412 ANDSER-784, AND MASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-412 AND SER-784, ANDMASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-194; SER-250; SER-306;SER-412 AND SER-784, AND MASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-784, AND MASSSPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-306, AND MASSSPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-306 AND SER-412, ANDMASS SPECTROMETRY.

TOP